Form 4: Nuvalent CFO Alexandra Balcom Executes Stock Sales Under 10b5-1 Plan

Alexandra Balcom, CFO of Nuvalent, Inc., executed multiple sales of Class A Common Stock on October 31, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 31, 2024, Alexandra Balcom, the Chief Financial Officer of Nuvalent, Inc., sold shares of Class A Common Stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 28, 2023.
• A total of 10,000 shares were acquired at a price of $27.85.
• Sales of Class A Common Stock occurred at varying weighted average prices: 1,980 shares at $88.25, 6,320 shares at $89.17, 1,600 shares at $90.31, and 100 shares at $90.94.
• Following these transactions, Balcom directly owns 33,300 shares of Class A Common Stock.
• Balcom also exercised a stock option for 10,000 shares at $27.85.
• After the reported transactions, Balcom beneficially owns 94,200 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment or misalignment of interests between management and shareholders.

Stakeholder Impact

• Shareholders may monitor these transactions to understand insider sentiment and potential implications for the stock price.

Key Dates